Ligand Pharma (LGND) Tops Q1 EPS by 29c, Offers FY Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SPY
9. SWKS
10. FISV

Go back to Ligand Pharma (LGND) Tops Q1 EPS by 29c, Offers FY Guidance

Ligand Reports First Quarter 2021 Financial Results

May 3, 2021 4:01 PM EDT

Conference Call Begins at 4:30 p.m. Eastern Time Today

SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2021 and provided an operating forecast and program updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern time to discuss this announcement and answer questions.

This year has opened strong for Ligand with solid financial performance and great results from all of our core technology platforms, said John Higgins, Chief Executive Officer. We are very... More